Literature DB >> 12377750

Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia.

Jeffrey B Boord1, Kazuhisa Maeda, Liza Makowski, Vladimir R Babaev, Sergio Fazio, MacRae F Linton, Gökhan S Hotamisligil.   

Abstract

OBJECTIVE: The adipocyte fatty acid-binding protein, aP2, has important effects on insulin resistance, lipid metabolism, and atherosclerosis. Its expression in macrophages enhances early foam cell formation and atherosclerosis in vivo. This study was designed to determine whether aP2 deficiency has a similar effect in the setting of advanced atherosclerosis and severe hypercholesterolemia. METHODS AND
RESULTS: Mice deficient in aP2 and apolipoprotein E (aP2(-/-)apoE(-/-) mice) and apolipoprotein E-deficient control mice (apoE(-/-) mice) were fed a Western diet for 14 weeks. No significant differences in fasting serum levels of cholesterol, triglycerides, or free fatty acids were found between groups for each sex. Compared with apoE(-/-) control mice, male and female aP2(-/-)apoE(-/-) mice had significant reductions in mean atherosclerotic lesion size in the proximal aorta, en face aorta, and innominate/right carotid artery. Feeding the Western diet in the apoE-deficient background did not cause a significant reduction in insulin sensitivity in vivo, as determined by steady-state serum glucose levels and insulin tolerance testing.
CONCLUSIONS: These data demonstrate an important role for aP2 expression in the advanced stages of atherosclerotic lesion formation. Thus, aP2 provides an important physiological link between different features of the metabolic syndrome and is a potential target for therapy of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12377750      PMCID: PMC4027051          DOI: 10.1161/01.atv.0000033090.81345.e6

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  29 in total

Review 1.  Physiological properties and functions of intracellular fatty acid-binding proteins.

Authors:  N R Coe; D A Bernlohr
Journal:  Biochim Biophys Acta       Date:  1998-04-22

2.  Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice.

Authors:  T Cyrus; J L Witztum; D J Rader; R Tangirala; S Fazio; M F Linton; C D Funk
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

3.  Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice.

Authors:  R J Aiello; P A Bourassa; S Lindsey; W Weng; E Natoli; B J Rollins; P M Milos
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-06       Impact factor: 8.311

4.  Altered circadian responses to light in streptozotocin-induced diabetic mice.

Authors:  E Challet; O van Reeth; F W Turek
Journal:  Am J Physiol       Date:  1999-08

5.  Leukocyte low density lipoprotein receptor (LDL-R) does not contribute to LDL clearance in vivo: bone marrow transplantation studies in the mouse.

Authors:  S Fazio; A H Hasty; K J Carter; A B Murray; J O Price; M F Linton
Journal:  J Lipid Res       Date:  1997-02       Impact factor: 5.922

6.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.

Authors:  L Gu; Y Okada; S K Clinton; C Gerard; G K Sukhova; P Libby; B J Rollins
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

7.  Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet.

Authors:  S Merat; F Casanada; M Sutphin; W Palinski; P D Reaven
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-05       Impact factor: 8.311

8.  Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein.

Authors:  G S Hotamisligil; R S Johnson; R J Distel; R Ellis; V E Papaioannou; B M Spiegelman
Journal:  Science       Date:  1996-11-22       Impact factor: 47.728

9.  Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.

Authors:  K T Uysal; S M Wiesbrock; M W Marino; G S Hotamisligil
Journal:  Nature       Date:  1997-10-09       Impact factor: 49.962

10.  Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages.

Authors:  S Fazio; V R Babaev; A B Murray; A H Hasty; K J Carter; L A Gleaves; J B Atkinson; M F Linton
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

View more
  60 in total

Review 1.  Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses.

Authors:  Liza Makowski; Gökhan S Hotamisligil
Journal:  J Nutr       Date:  2004-09       Impact factor: 4.798

Review 2.  Nutrition and metabolic correlates of obesity and inflammation: clinical considerations.

Authors:  Amy R Johnson; Liza Makowski
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

3.  Unsaturated fatty acids repress the expression of adipocyte fatty acid binding protein via the modulation of histone deacetylation in RAW 264.7 macrophages.

Authors:  Sara L Coleman; Young-Ki Park; Ji-Young Lee
Journal:  Eur J Nutr       Date:  2010-11-03       Impact factor: 5.614

Review 4.  Aggressive Crosstalk Between Fatty Acids and Inflammation in Macrophages and Their Influence on Metabolic Homeostasis.

Authors:  Kazuhiro Nishiyama; Yasuyuki Fujimoto; Tadayoshi Takeuchi; Yasu-Taka Azuma
Journal:  Neurochem Res       Date:  2017-04-19       Impact factor: 3.996

Review 5.  Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy.

Authors:  Amir Abbas Momtazi-Borojeni; Elham Abdollahi; Banafsheh Nikfar; Shahla Chaichian; Mahnaz Ekhlasi-Hundrieser
Journal:  Heart Fail Rev       Date:  2019-05       Impact factor: 4.214

6.  Serum adipocyte fatty acid-binding protein is independently associated with complex coronary lesions in patients with stable coronary artery disease.

Authors:  Masahito Kajiya; Toru Miyoshi; Masayuki Doi; Shinichi Usui; Mutsumi Iwamoto; Ko Takeda; Kazumasa Nosaka; Rie Nakayama; Satoshi Hirohata; Shozo Kusachi; Kazufumi Nakamura; Hiroshi Ito
Journal:  Heart Vessels       Date:  2012-12-09       Impact factor: 2.037

7.  Fatty-acid binding protein 4 gene variants and childhood obesity: potential implications for insulin sensitivity and CRP levels.

Authors:  Abdelnaby Khalyfa; Bharat Bhushan; Mohamed Hegazi; Jinkwan Kim; Leila Kheirandish-Gozal; Rakesh Bhattacharjee; Oscar Sans Capdevila; David Gozal
Journal:  Lipids Health Dis       Date:  2010-02-15       Impact factor: 3.876

8.  Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells.

Authors:  Harun Elmasri; Cagatay Karaaslan; Yaroslav Teper; Elisa Ghelfi; Meiqian Weng; Tan A Ince; Harry Kozakewich; Joyce Bischoff; Sule Cataltepe
Journal:  FASEB J       Date:  2009-07-22       Impact factor: 5.191

9.  Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.

Authors:  Jeffrey B Boord; Kazuhisa Maeda; Liza Makowski; Vladimir R Babaev; Sergio Fazio; MacRae F Linton; Gökhan S Hotamisligil
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

10.  Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis.

Authors:  Ebru Erbay; Vladimir R Babaev; Jared R Mayers; Liza Makowski; Khanichi N Charles; Melinda E Snitow; Sergio Fazio; Michelle M Wiest; Steven M Watkins; Macrae F Linton; Gökhan S Hotamisligil
Journal:  Nat Med       Date:  2009-11-29       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.